Factors associated with glycemic control in patients with T2DM: evidence from a cross-sectional study in China-Reference-Cited by-同舟云学术

Factors associated with glycemic control in patients with T2DM: evidence from a cross-sectional study in China

Published:2024-02-13 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Luo Wenting¹,Zhang Jiayu¹,Luo Yanxing²,Wu Qiuwan¹,Chen Longfei¹,Liu Changqin¹,Lin Minqiang¹

Affiliation:

1. The First Affiliated Hospital of Xiamen University School of Medicine, Xiamen University

2. Fujian Medical University

Abstract

Abstract ObjectiveThis study aimed to analyze the factors influencing glycemic control in patients with type 2 diabetes mellitus (T2DM). MethodsBaseline data, encompassing basic information, lifestyle habits, and treatment of 305 T2DM patients from March 2021 to January 2023, were collected and analyzed using SPSS 26.0 software. Results: Univariate and multivariate logistic regression analyses identified insulin therapy (OR=2.233, P=0.026) and regular clinic visits (OR=0.567, P=0.040) as independent factors influencing glycemic control. No observed interactions between the two variables were noted. Conclusion: History of insulin therapy and regular clinic visits were significantly and independently associated with glycated hemoglobin control in T2DM patients. Tailored interventions based on individual circumstances are recommended to optimize glycemic control.

Publisher

Research Square Platform LLC

Reference14 articles.

1. Diabetes insipidus;Christ-Crain M;Nat Rev Dis Primers,2019

2. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications;Zheng Y;Nat Rev Endocrinol,2018

3. Factors associated with glycemic control among patients with type 2 diabetes: a cross-sectional study;Al-Qerem W;Eur Rev Med Pharmacol Sci,2022

4. [Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)]. Zhonghua Nei Ke Za Zhi, 2022. 61(1): p. 12–50.

5. Glycemic control and its associated factors in hypertensive patients with type 2 diabetes;Jarab AS;Eur Rev Med Pharmacol Sci,2023